documents: FDA-2024-C-0971-0005

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2024-C-0971-0005 FDA FDA-2024-C-0971 Reference 2 - Memorandum from H. Thapa, Chemistry Evaluation Branch, DFI, OPMAS, HFP, FDA to S. DiFranco, RMB, DFI, OPMAS, HFP, FDA, April 21, 2025. Supporting & Related Material Background Material 2025-05-12T04:00:00Z 2025 5     2025-05-21T22:23:27Z   0 0 09000064b8d0906e

Links from other tables